Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.

Literature DB >> 23914021

Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.

Abstract

Entities: Disease Species

Keywords: Cardiovascular diseases/blood/prevention & control; dyslipidemias/drug therapy; female; hypercholesterolemia/drug therapy; lipids/blood; lipoprotein(a)/blood; randomized controlled trials as topic; triglycerides/blood; women's health

Mesh：

Substances：

Year: 2013 PMID： 23914021 PMCID： PMC3709236

Source DB: PubMed Journal: Tex Heart Inst J ISSN： 0730-2347

× No keyword cloud information.

11 in total

Review 1. Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis.

Authors: Radhika N Bukkapatnam; Nicole B Gabler; William R Lewis
Journal: Prev Cardiol Date: 2010

2. Statin use in outpatients with obstructive coronary artery disease.

Authors: Suzanne V Arnold; John A Spertus; Fengming Tang; Harlan M Krumholz; William B Borden; Steven A Farmer; Henry H Ting; Paul S Chan
Journal: Circulation Date: 2011-11-07 Impact factor: 29.690

3. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease.

Authors: Salim S Virani; LeChauncy D Woodard; Supicha S Chitwood; Cassie R Landrum; Tracy H Urech; Degang Wang; Jeffrey Murawsky; Christie M Ballantyne; Laura A Petersen
Journal: Am Heart J Date: 2011-08-25 Impact factor: 4.749

4. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors: Salim S Virani; Ariel Brautbar; Brian C Davis; Vijay Nambi; Ron C Hoogeveen; A Richey Sharrett; Josef Coresh; Thomas H Mosley; Joel D Morrisett; Diane J Catellier; Aaron R Folsom; Eric Boerwinkle; Christie M Ballantyne
Journal: Circulation Date: 2011-11-29 Impact factor: 29.690

5. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.

Authors: Samia Mora; Robert J Glynn; Judith Hsia; Jean G MacFadyen; Jacques Genest; Paul M Ridker
Journal: Circulation Date: 2010-02-22 Impact factor: 29.690

6. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors: A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal: Circulation Date: 2001-09-04 Impact factor: 29.690

Review 7. Statins for the primary prevention of cardiovascular disease.

Authors: Fiona Taylor; Kirsten Ward; Theresa Hm Moore; Margaret Burke; George Davey Smith; Juan-Pablo Casas; Shah Ebrahim
Journal: Cochrane Database Syst Rev Date: 2011-01-19

Review 8. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.

Authors: J J Brugts; T Yetgin; S E Hoeks; A M Gotto; J Shepherd; R G J Westendorp; A J M de Craen; R H Knopp; H Nakamura; P Ridker; R van Domburg; J W Deckers
Journal: BMJ Date: 2009-06-30

9. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.

Authors: Nadeem Sarwar; John Danesh; Gudny Eiriksdottir; Gunnar Sigurdsson; Nick Wareham; Sheila Bingham; S Matthijs Boekholdt; Kay-Tee Khaw; Vilmundur Gudnason
Journal: Circulation Date: 2006-12-26 Impact factor: 29.690

10. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors: C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal: Lancet Date: 2010-11-08 Impact factor: 79.321

4 in total